About Andromeda
Care homes and assisted-living providers use Andromeda's companion robots to engage residents and support staff. Abi adapts its behavior to each resident's personality, abilities and language. It provides conversation and activities while adding capacity for care teams. The original design also targeted children in hospitals.
Co-founder and chief executive Grace Brown helped launch Andromeda in 2022. It has offices in Southbank, Victoria, and San Francisco. mecwacare deployed Abi in all 22 homes. Allity, part of Bolton Clarke Group, ran early trials in Victoria. Medical & Aged Care Group also uses Abi in its homes. Eskaton Village Carmichael became Andromeda's first U.S. senior-living partner after its March launch.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | Nov 13, 2026 | $30,020,303of $75.0M target | 17 | $1.7M | EquityRule 506(b) | Form D ↗ |
| Sep 5, 2025 | Sep 22, 2025 | $14,110,182of $15.7M target | 14 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $44,130,485 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
What the SEC Filings Show
- Jesse Dorogusker first appears as a director on the Form D that Andromeda filed on November 13, 2026. [10]
- Derek Gerrard of Purpose Ventures, which led the seed round, first appears as a director on the Form D that Andromeda filed on September 22, 2025. [11][7]Form D filings that name Derek Gerrard (2):
- Andromeda, managing Director: Sep 22, 2025 · Nov 13, 2026
Who Invested in Andromeda
Scroll table to see all columns →
| Announced | Round | Amount | Lead | Other investors | On the Form D | Source |
|---|---|---|---|---|---|---|
| 2023 | Pre-seed | $1 million | — | Galileo Ventures | [7] | |
| — | Series A | $23 million | — | ReturningStartmate; Purpose Ventures. | [6] | |
| — | Seed | $3 million | Purpose Ventures | — | [7] |
Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
Why Investors Backed Andromeda
Main Sequence sees a growing care-worker shortage as people live longer and fewer people are available to care for them. It chose Andromeda after watching residents engage and hearing an early customer call the first robot already life-changing. The firm also valued Andromeda's integrated hardware, AI and care-specific form factor. [9]
Origin and Team
Robotics engineer Grace Brown launched Andromeda in 2022. Her experience with loneliness during the COVID pandemic sparked both the company and Abi. [7][6]
Product and Technology
Abi uses machine vision, artificial intelligence and GPT-4 to recognize residents, answer questions and adapt conversations from earlier interactions. It also recognizes faces, remembers information and expresses emotions. The 120-centimeter robot gestures and moves its head and eyes during conversations. Its character design draws on Disney and Pixar animators. Advisers from Pixar and DreamWorks helped shape its body language. [7][8]
Customers will be able to customize Abi's personality through an app, including salesperson or motivational-coach archetypes. Abi can assist with daily tasks and provide social and cognitive support. [7]
Genesis Abi was co-developed with mecwacare for greater autonomy and stronger multilingual and listening abilities. It adds features for people with dementia and can move independently between group activities and residents' rooms. The new version can converse in up to 90 languages. [5][6]
Use of Funds
- The Series A will expand Andromeda's Australian team and production to serve more aged-care partners. [6]
- The Series A will fund the launch of Genesis Abi. [6]
- The Series A will support U.S. expansion and hiring for creative and animation robotics roles. [6]
- The seed round funded Abi upgrades, hiring and a larger manufacturing site in South Melbourne. [7]
Market
Main Sequence cites a World Health Organization projection of a roughly 11 million-person global health and care worker shortfall by 2030. The investor also cites an expected Australian gap of 110,000 workers over the same period. [9]
Andromeda expects home companion robots to see broad adoption. It is starting in aged care, where it sees the greatest need for meaningful connection. [6]
We wrote this summary from public statements by Andromeda and its investors. It is not investment advice.
Leadership Team
Executive officers and directors listed on Andromeda's Form D filed Nov 13, 2026.


Sources
- CompanyAndromeda home and product overview · linked above ↑
- CompanyAndromeda team
- CompanyAndromeda contact
- CompanyAndromeda news and deployments
- CompanyGenesis Abi launch
- CompanySeries A funding news
- CompanyAndromeda seed funding article
- CompanyAndromeda aged-care trials article
- InvestorMain Sequence investment in Andromeda Robotics
- SECAndromeda Form D, filed 2026-11-13 · linked above ↑
- SECAndromeda Form D, filed 2025-09-22 · linked above ↑
- SECANDROMEDA ROBOTICS, INC. filing history
